Migrainous stroke and the antiphospholipid antibodies

M. Silvestrini, M. Matteis, E. Troisi, L. M. Cupini, G. Zaccari, G. Bernardi

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

The pathogenesis of migrainous stroke is controversial. The possibility that a number of migraine-related strokes is associated with the presence of antiphospholipid antibodies, a condition predisposing to coagulopathy, has been suggested. We investigated the prevalence of lupus anticoagulant and anticardiolipin antibodies in patients with migrainous stroke. In 6 out of 16 patients with migrainous cerebral infarction, the presence of antiphospholipids antibodies was detected. In such patients, the presence of other risk factors for stroke was significantly lower (χ2 = 5.6, p = 0.01) with respect to patients with negative results for antiphospholipid antibodies. These results suggest that antiphospholipid antibodies associated with migraine may be an important marker for ischemic stroke.

Original languageEnglish
Pages (from-to)316-319
Number of pages4
JournalEuropean Neurology
Volume34
Issue number6
Publication statusPublished - 1994

Fingerprint

Antiphospholipid Antibodies
Stroke
Migraine Disorders
Lupus Coagulation Inhibitor
Anticardiolipin Antibodies
Cerebral Infarction

Keywords

  • Anticardiolipin antibodies
  • Lupus anticoagulant
  • Migranous stroke

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Silvestrini, M., Matteis, M., Troisi, E., Cupini, L. M., Zaccari, G., & Bernardi, G. (1994). Migrainous stroke and the antiphospholipid antibodies. European Neurology, 34(6), 316-319.

Migrainous stroke and the antiphospholipid antibodies. / Silvestrini, M.; Matteis, M.; Troisi, E.; Cupini, L. M.; Zaccari, G.; Bernardi, G.

In: European Neurology, Vol. 34, No. 6, 1994, p. 316-319.

Research output: Contribution to journalArticle

Silvestrini, M, Matteis, M, Troisi, E, Cupini, LM, Zaccari, G & Bernardi, G 1994, 'Migrainous stroke and the antiphospholipid antibodies', European Neurology, vol. 34, no. 6, pp. 316-319.
Silvestrini M, Matteis M, Troisi E, Cupini LM, Zaccari G, Bernardi G. Migrainous stroke and the antiphospholipid antibodies. European Neurology. 1994;34(6):316-319.
Silvestrini, M. ; Matteis, M. ; Troisi, E. ; Cupini, L. M. ; Zaccari, G. ; Bernardi, G. / Migrainous stroke and the antiphospholipid antibodies. In: European Neurology. 1994 ; Vol. 34, No. 6. pp. 316-319.
@article{3ebed1706ba44edc868ee9a54df81eae,
title = "Migrainous stroke and the antiphospholipid antibodies",
abstract = "The pathogenesis of migrainous stroke is controversial. The possibility that a number of migraine-related strokes is associated with the presence of antiphospholipid antibodies, a condition predisposing to coagulopathy, has been suggested. We investigated the prevalence of lupus anticoagulant and anticardiolipin antibodies in patients with migrainous stroke. In 6 out of 16 patients with migrainous cerebral infarction, the presence of antiphospholipids antibodies was detected. In such patients, the presence of other risk factors for stroke was significantly lower (χ2 = 5.6, p = 0.01) with respect to patients with negative results for antiphospholipid antibodies. These results suggest that antiphospholipid antibodies associated with migraine may be an important marker for ischemic stroke.",
keywords = "Anticardiolipin antibodies, Lupus anticoagulant, Migranous stroke",
author = "M. Silvestrini and M. Matteis and E. Troisi and Cupini, {L. M.} and G. Zaccari and G. Bernardi",
year = "1994",
language = "English",
volume = "34",
pages = "316--319",
journal = "European Neurology",
issn = "0014-3022",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - Migrainous stroke and the antiphospholipid antibodies

AU - Silvestrini, M.

AU - Matteis, M.

AU - Troisi, E.

AU - Cupini, L. M.

AU - Zaccari, G.

AU - Bernardi, G.

PY - 1994

Y1 - 1994

N2 - The pathogenesis of migrainous stroke is controversial. The possibility that a number of migraine-related strokes is associated with the presence of antiphospholipid antibodies, a condition predisposing to coagulopathy, has been suggested. We investigated the prevalence of lupus anticoagulant and anticardiolipin antibodies in patients with migrainous stroke. In 6 out of 16 patients with migrainous cerebral infarction, the presence of antiphospholipids antibodies was detected. In such patients, the presence of other risk factors for stroke was significantly lower (χ2 = 5.6, p = 0.01) with respect to patients with negative results for antiphospholipid antibodies. These results suggest that antiphospholipid antibodies associated with migraine may be an important marker for ischemic stroke.

AB - The pathogenesis of migrainous stroke is controversial. The possibility that a number of migraine-related strokes is associated with the presence of antiphospholipid antibodies, a condition predisposing to coagulopathy, has been suggested. We investigated the prevalence of lupus anticoagulant and anticardiolipin antibodies in patients with migrainous stroke. In 6 out of 16 patients with migrainous cerebral infarction, the presence of antiphospholipids antibodies was detected. In such patients, the presence of other risk factors for stroke was significantly lower (χ2 = 5.6, p = 0.01) with respect to patients with negative results for antiphospholipid antibodies. These results suggest that antiphospholipid antibodies associated with migraine may be an important marker for ischemic stroke.

KW - Anticardiolipin antibodies

KW - Lupus anticoagulant

KW - Migranous stroke

UR - http://www.scopus.com/inward/record.url?scp=0027941727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027941727&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 316

EP - 319

JO - European Neurology

JF - European Neurology

SN - 0014-3022

IS - 6

ER -